1.gif (1892 bytes)

Brief Reports

Indian Pediatrics 2005; 42:146-149 

Cardiac Dysfunction in HIV Infected Children : A Pilot Study

 

*Ira Shah, S.S. Prabhu, Sumitra V. and H.S. Shashikiran*

From the Department of Pediatric Cardiology and Pediatric HIV Clinic*, Bai Jerbai Wadia Hospital for Children, Acharya Dhonde Marg, Parel, Mumbai 400 012, India.

Correspondence to: Dr. Ira Shah, 240 D, Walkeshwar Road, Malabar Hill, Mumbai 400 006,
India. E-mail: [email protected]

Manuscript received: October 14, 2003, Initial review completed: December 5, 2003;
Revision accepted: July 27, 2004.

Abstract:

Twenty six perinatally acquired HAART-naοve HIV positive children asymptomatic for cardiac disease in age group of 1-9 years were evaluated for cardiac abnormalities by echocardiography. All children were classified according to the revised CDC classification for HIV infection in children. 20 (76.9%) patients had evidence of cardiac abnormalities on echocardiography. 18 (69.2%) patients in category B had statistically significant abnormal echocardiographic finding (p<0.02). The commonest echocardiographic abnormalities seen were left ventricular dilatation in 10 (38.5%) and left ventricular hypertrophy in 10 (38.5%) patients. Echocardiographic abnormalities are present even in HIV-infected children who are asymptomatic for cardiac dysfunction.

Keywords: Acquired immunodeficiency syndrome, Human immunodeficiency virus, Echocardiography.

 

The incidence of cardiovascular disease reported amongst HIV infected children ranges from 72% to over 90%(1,2). Common cardiac abnormalities noted in HIV infected individuals include cardiomyopathy, myocarditis, pericardial effusion and pulmonary hypertension(3). Grenier, et al.(4) reported that cardiac disease was the primary cause of death in 25% of HIV positive patients. Studies carried out in Indian subcontinent have demonstrated the presence of diastolic dysfunction on echocardiography in HIV-infected adults(5). Considering the paucity of similar data regarding HIV-infected children in the Indian subcontinent, we conducted this study to determine the incidence and nature of sub-clinical cardiac abnormalities in HIV-infected children.

Subjects and Methods

Twenty six consecutive children in the age group from 1 year to 9 years with perinatally acquired human immunodeficiency virus (HIV) infection were prospectively evaluated for sub-clinical cardiac abnormalities at a tertiary pediatric teaching hospital with Pediatric Cardiology and Pediatric & Perinatal HIV sub-specialties, Mumbai, India over a period of 6 months following verbal informed consent. In children aged 18 months and above referred to us with a positive HIV ELISA test, HIV was tested by two different HIV antibody-third generation ELISA tests using DETECT- HIV MC (v.2) and HIV CHEX kits after informed consent from the parents/guardians. Both pre test and post test counseling was done. HIV infection was established on the basis of positive results obtained with both the kits. The diagnosis of HIV infection in children aged less than 18 months was based on positive result by HIV DNA qualitative PCR test using SK38 and SK39 primers. Vertical transmission was established by doing the maternal HIV testing.

HIV positive patients were classified into category N, A, B or C as per the revised (1994) Center for disease control (CDC) classification system for HIV infection in children(6). All subjects were assessed clinically for evidence of cardiac disease and underwent a 2-dimensional, M-mode echo-cardiography and Color Doppler analysis on Hewlett Packard Sonos 2000 machine to study the anatomy of the heart and its functional hemodynamics. The patients were evaluated for left ventricular systolic function in the form of fractional shortening and ejection fraction, left ventricular dimensions, left ventricular diastolic functions in form of mitral inflow velocities, valvular abnormali-ties and pericardial disease that were compared with the normal values(7).

Results

All the HIV infected children enrolled in the study ranged in the age group of 1 to 9 years. None of the enrolled subjects/their guardians reported the presence of cardiac symptoms such as cyanosis, breathlessness, fatigue, palpitations, chest pain, syncope or edema. On examination, no patient had evidence of tachycardia, arrhythmia, increased jugular venous pressure, clubbing, cardiomegaly, murmur or gallop. The commonest clinical manifestations seen were hepatosplenomegaly in 16 (61.5%), lymphadenopathy in 15 (57.7%), failure to thrive in 12 (46.2%), pulmonary and extra pulmonary tuberculosis in 10(38.5%), skin diseases in 6 (23.1%), pyrexia in 5(19.2%), oral candidiasis in 3 (11.5%), recurrent lower respiratory tract infections in 2 (7.7%), chronic parotitis in 1(3.8%), chronic otitis media in 1 (3.8%) and chronic diarrhea in 1 (3.8%) patient. When subjected to echocardiography, 20 patients (76.9%) demonstrated abnormal echocardiographic findings as illustrated in Table I.

TABLE I

HIV Infection in Children – Clinical Category and Echocardiographic Findings.
Clinical category
 
Abnormal echocardiographic
findings n(%)
N
2(50.0)
A
2(66.7)
B
16(88.9)
C
0(0)

Left ventricular dilatation and left ventricular hypertrophy were the most frequent echocardiographic abnormalities (Table II). All 3 patients with pericardial effusion had suffered from pulmonary tuberculosis in the past and received anti-tuberculous therapy. None of the patients expired during the study.

TABLE II

Common Echocardiographic Abnormalities in HIV Positive Children.
Echocardiographic findings CDC category Total Percentage
N A B C
Normal 2 1 2 1 6 23.1%
Decreased left ventricular systolic function 
–
1
4
–
5
19.2%
Left ventricular dilation
2
–
8
–
10
38.5%
Left ventricular hypertrophy
1
–
9
–
10
38.5%
Mild Tricuspid regurgitation
–
–
3
–
3
11.5%
Pericardial effusion 
–
–
3
–
3
11.5%
Right ventricular enlargement
–
–
1
–
1
3.9%

 

Discussion

HIV-infected adults are known to have cardiac involvement in the form of diseases of the pericardium, epicardium, myocardium and the endocardium(8). Although pathogenesis of cardiac involvement in HIV infection is uncertain; autoimmunity, autonomic dysfunction and abnormal ventricular growth have been proposed as the possible mechanisms(1,9).

Cardiac involvement in HIV infected children is sub-clinical and progressive. Clinical examination, chest radiographs and electrocardiography may pick up manifest cardiac disease. Sub-clinical manifestations such as left ventricular dilatation, hypertrophy and decreased systolic dysfunction can be detected only by echocardiography. Progressive left ventricular dilatation is common in HIV-1 positive children and may be a harbinger of congestive cardiac failure. In many HIV infected children, dilatation is associated with inadequate left ventricular hypertrophy, elevated afterload and reduced left ventricular (LV) function(10).

In this study 20 patients (76.9%) had evidence of sub-clinical cardiac abnormality, which is similar to other reports that have ranged from 72% to over 90%(1,2). Left ventricular dilatation and left ventricular hypertrophy (38.5% each) were the commonest abnormal echocardiographic findings in our study as also seen in P2C2 multi-centric study(10). Direct cytotrophic effect of HIV virus on cardiac cells has been proposed to be the cause of progressive dilatation of left ventricle in HIV infected children(11) and its incidence is found to range from 5-30%(12,13). Decreased left ventricular systolic function is seen when the ventricular hypertrophy fails to keep with progressive left ventricular dilatation. The incidence of decreased left ventricular systolic function of 19.2% in our study corresponds to those found in other studies(1,12). One patient had right ventricular enlargement and isolated right ventricular enlargement has been postulated to be secondary to repetitive pulmonary infection and not due to myocardial disease(1). Similarly, tricuspid regurgitation may be seen in patients with recurrent lung infections(14), which were present in 11.5% of our patients. The relationship of cardiac abnormalities to the stage of HIV infections remains still obscure. We found that cardiac abnormalities were more frequently associated with category B (69.2%).

Annual echocardiography examination is recommended to evaluate the progression of cardiac disease and treat the same before it becomes irreversible in HIV infected children. Effects of ART may confound the effects on the heart and cardiac assessment may be required in patients on HAART. Immuno-modulation with IVIG has been previously reported to normalize the LV dysfunction in HIV-1 infected children(15), but needs further evaluation.

Acknowledgement

The authors thank Dr. Dod, Chief Senior Executive of B. J. Wadia Hospital for Children for giving permission to publish this article.

Contributors: HS & SV conducted the study, IS drafted the manuscript and conducted the statistical analysis. SSP prepared the study design, supervised the study - will act as the guarantor of the study.

Funding: None.

Competing interests: None stated.

 

 References

 

1. Lipshultz SE, Chanock S, Sanders SP, Colan SD, Perez-Atayde A, McIntosh K. Cardio-vascular manifestations of human immuno-deficiency virus infection in infants and children. Am J Cardiol 1989; 63: 1489-1497.

2. Luginbuhl LM, Orav EJ, McIntosh K, Lipshultz SE. Cardiac morbidity and related mortality in children with HIV infection. JAMA 1993; 269: 2869-2875.

3. Barbaro G. Cardiovascular manifestations of HIV infection. Circulation 2002; 106: 1420-1425.

4. Grenier MA, Karr SS, Rakusan JA, Martin GR. Cardiac disease in children with HIV: relationship of cardiac disease to HIV sympto-matology. Pediatric Aids 1994; 5: 174-179.

5. S Mishra, N Wig, CM Mittal, RM Pandey, G Karthikeyan, P Arora, VK Bahl. Diastolic Dysfunction in Human Immunodeficiency Virus (HIV)-Infected Patients in North India. Indian Heart Journal 2003; 55: 166-168.

6. Centers for Disease Control & Prevention. Revised classification for human immuno-deficiency virus infection in children less than 13 years of age. MMWR, Morb Mortal Weekly Rep 1994; 43: 11-17.

7. Henry WL, Ware J, Makay K, Wiedner H. Echocardiographic measurements in normal subjects, growth related changes that occur between infancy and early adulthood. Circulation 1987; 57: 278-285.

8. Francis CK. Cardiac involvement in AIDS. Curr Probl Cardiol 1990; 15: 571-589.

9. P F Currie, J H Goldman, A L P Caforio, A J Jacob, M K Baig, R P Brettle, et al. Cardiac autoimmunity in HIV related heart muscle disease. Heart 1998; 79: 599-604.

10. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, et al. Cardiac dysfunction and mortality in HIV-infected children: The prospective P2C2 HIV multicenter study. Pediatric pulmonary and cardiac complications of vertically transmitted HIV infection (P2C2 HIV) study group. Circulation 2000; 102: 1542-1548.

11. Lipshultz SE, Sander SP, Colan SD. Cardiac structure and function in HIV infected children. New Engl J Med 1993; 328: 513-514.

12. Werneck GL, Mesquita ET, Romeo Filho LJ, Ribeiro ML. Doppler echocardiographic evaluation of HIV-positive patients in different stages of the disease. Arq Bras Cardiol 1999; 73: 157-168.

13. Cardoso JS, Miranda AM, Moura B, Gomes MH, Oliveira P, Conde C, et al. Cardiac morbidity in HIV disease. Rev Port Cardiol 1994; 13: 901-911.

14. Coudray N, de Zuttere D, Force G, Champetier de Ribes D, Pourny JC, Antony I, et al. Left ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur Heart J 1995; 16: 61-67.

15. Lipshultz SE, Orav EJ, Sanders SP, Colan SD. Immunoglobulins and left ventricular structure and function in pediatric HIV infection. Circulation 1995; 92: 2220-2225.

.

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription